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Abstract 
Gender Minority Experiences of Healthcare Discrimination, State Policy Protections, and Care 
Avoidance  
By Sean Luong 
Background: Discrimination experiences of gender minority people likely contribute to their 
health and access to healthcare. Objective: To explore the associations between lifetime 
healthcare discrimination, state policy protections for gender minorities, and incidence of care 
avoidance among transfeminine, transmasculine, and gender expansive groups. Methods: The 
Population Research in Identities and Disparities for Equality (PRIDE) study is an online, 
longitudinal study collecting health data from sexual and gender minority (SGM) people. 
Movement Advancement Project (MAP) is an organization that gathers data on LGBTQ policies 
and laws. This study was an ancillary analysis regarding reported healthcare discrimination and 
care avoidance from PRIDE study respondents in the 2018 annual survey. Participants were 
further identified as living in a state with overall harmful or protective policies. Logistic 
regression modelling explored relationships between lifetime healthcare discrimination and state 
policy to care avoidance in two separate models and then looked at both predictors to care 
avoidance in a third model. Results: Among the 309 transfeminine participants, 580 
transmasculine participants, and 1,675 gender expansive participants, all groups had higher odds 
of care avoidance after exposure to healthcare discrimination (OR: 7.81  CI: 3.35 - 17.15 in the 
transfeminine group, OR: 3.15 CI: 2.03 - 4.90 in the transmasculine group, and OR 4.31 CI: 3.34 
– 5.57 in the gender expansive group; P < 0.001 for all). Findings on state policy and care 
avoidance were not statistically significant. With both predictors in the model, odds of care 
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avoidance associated with experiencing lifetime healthcare discrimination were greater than the 
odds of care avoidance for participants living in a state with harmful healthcare policies 
(ORs(95% CIs): 8.29 (3.75 –18.34) vs. 1.28 (0.67 – 2.44) in the transfeminine group, 3.15 (2.02 
– 4.90) vs. 1.28 (0.83 – 1.98) in the transmasculine group, and 4.23 (3.28 – 5.47) vs. 1.21 (0.938 
– 1.57) in the gender expansive group; P < 0.001 for lifetime healthcare discrimination 
predictors). Conclusion: Discrimination is associated with varying degrees of decreased access to 
care for gender minority people and potentially negative health impacts. Further research on 
intersectionality of gender minority people’s identities may improve understanding regarding 
how to increase health equity for gender minority people. 
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BACKGROUND 
Transgender, also trans, describes a population of people with a range of diverse gender 
identities that do not exclusively align with one’s sex assigned at birth1. While transgender is an 
umbrella term, not every gender-diverse individual identifies as a transgender person. They may 
identify with a transfeminine identity (e.g. woman or trans woman), a transmasculine identity 
(e.g. man or trans man), or a gender expansive identity (e.g. gender nonconforming, gender fluid, 
agender) that is incongruent to their sex assigned at birth. Cisgender describes those whose 
gender identity are typically associated with their sex assigned at birth. Modern society has 
upheld a binary cisgender system, meaning everyone is assumed to be either male or female, 
based on their sex assigned at birth2. Gender minority people are individuals who do not identify 
with a cisgender identity. 
 A substantial body of literature provides evidence that that trans people experience 
stigma related to gender identity3-7. Stigma is defined as the social process of labeling, 
stereotyping, separation, status loss, and discrimination as a means of social control8. Stigma is a 
social construct that comprises of these defined social processes, most tangibly discrimination, 
working at structural, interpersonal and individual levels of society. Structural oppression that 
results from stigma can affect access to critical resources, such as income, education, housing, 
and healthcare4,6,9-11.  
Discrimination related to gender identity impacts health outcomes both directly and 
indirectly. Transgender discrimination experiences are associated with negative psychological 
outcomes, including increased rates of depression, anxiety, and alcohol and substance use14,16-18. 
Among transgender-identified adults, there is a 40% occurrence of lifetime suicide attempts, 
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compared to a 4.6% occurrence in the general population9,18,19. Transgender discrimination 
results in restriction of access to resources, such as education, income, and health insurance. This 
restriction can result in additional barriers to accessing health care and achieving optimal 
health9,12,15.  In the 2015 US Transgender Survey, 25% of respondents experienced a problem 
with their health insurance due to being transgender, such as being denied coverage7. When 
seeing their health care provider, 33% of trans respondents reported mistreatment and only 65% 
of respondents received the gender affirming treatment they desired7. Barriers to accessing health 
care that arise from discrimination may prevent gender minority individuals from expressing 
their gender identity, further contributing to overall stigma.  
Hatzenbuehler et. al. argue that stigma is a fundamental cause of, and a factor continually 
associated with, health inequalities4,22. Stigma is enacted through multiple social mechanisms 
that influence social determinants contributing to health inequality4,6,20. As social mechanisms 
such as laws and attitudes are formed, transgender stigma and health inequalities are 
perpetuated4,6. Discrimination is both a feature of stigma and a component in establishing stigma. 
Discrimination is characterized by actions or social conditions that exclude individuals or treat 
them unequally based on a perceived identity4,24. Discrimination operates at the structural, 
interpersonal and individual levels of society. Laws barring insurance coverage for gender 
affirming treatments reflect transgender discrimination at the structural level. Health care 
providers refusing to treat or mistreating trans patients reflects transgender discrimination at the 
interpersonal level. Trans people deciding not to seek out a health care provider for their health 
needs because they fear mistreatment or being disrespected reflects internalized transgender 
discrimination at the individual level.  The modified social-ecological model of transgender 
stigma6 conceptualizes how discrimination may operate as social mechanisms of transgender 
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stigma (Figure 1). To understand stigma’s role in transgender health inequality, a look into the 
relationship between structural, interpersonal, and individual levels of discrimination is required.  
Previous studies have described care avoidance within the transgender population due to 
past experiences of discrimination from health care providers6,21. The 2015 U.S. Transgender 
Survey found that 23% of respondents reported that they did not seek care due to fear of 
disrespect or mistreatment7. A study of 452 trans people conducted in 2013 reported that 
experiences of healthcare discrimination were independently associated with a 2.43 higher 
likelihood of care avoidance for preventative care and a 3.41 higher likelihood of care avoidance 
when sick or injured 21. In addition to individual and interpersonal-level factors, recent studies on 
transgender discrimination have expanded to include structural-level variables. A study using 
data from the National Transgender Discrimination Survey sought to define individual and state-
level factors that are associated with healthcare providers declining to treat transgender patients 
(i.e., care refusal) based on responses from 5,381 trans people10. Multiple individual-level factors 
(i.e., age, race, income, care avoidance) and one state-level factor (i.e., percentage voting 
Republican) were positively associated with healthcare providers refusing to provide care to 
individuals who identify as transgender.  
The purpose of this study was to assess relationships between structural-level discrimination 
(e.g. state healthcare policies) and interpersonal discrimination (e.g. healthcare discrimination) 
with individual-level internalized discrimination (e.g. care avoidance) amongst individuals who 
identify as transfeminine, transmasculine, or gender expansive. Previous studies have shown an 
association between mistreatment in healthcare and care avoidance but have not looked at 
correlation with structural stigma6,21. Studies that have looked at structural stigma, simply 
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analyzed state-level demographics or noted the presence of one or two transgender protective 
laws5,10. Stratifying states by the amount of gender identity state policies on healthcare will 
potentially provide more nuanced interpretation of structural stigma data. We hypothesize that: 
[1] Experiencing mistreatment or disrespect in healthcare settings previously will impact the 
likelihood of not seeing a healthcare provider when needed in the past year; [2] Living in a state 
with overall harmful healthcare policies related to gender identity is related to not seeing a 
healthcare provider when needed in the past year; [3] Care avoidance in the past year will have a 
stronger association with lifetime healthcare discrimination than living in a state with harmful 
healthcare policy for gender minority people. . Associations between different mechanisms of 
transgender stigma can help us explore how stigma is linked to health inequity among 
transgender and gender expansive individuals
 
METHODS 
This study analyzed data collected from the Population Research in Identities and 
Disparities for Equality (PRIDE) Study and the Movement Advancement Project (MAP). We 
included a subgroup of participants (n=2,574) from the PRIDE Study who identified with a 
transfeminine, transmasculine, or gender expansive identity and provided responses to survey 
questions about healthcare discrimination and care avoidance in 2018. The MAP database 
provided data on health policies related to gender equality for each state in the U.S for 2018. The 
Institutional Review Board at the University of California, San Francisco and Stanford 
University, as well as the Research Advisory Committee and Participant Advisory Committee 
for the PRIDE study approved this study.  
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The PRIDE Study 
The PRIDE study is a national, online, longitudinal cohort study designed to collect 
demographic and health data about sexual and gender minority (SGM) people in order to 
understand their specific health needs and health inequity. The PRIDE Study applies a 
community engagement approach by involving participants to generate pertinent research 
questions and through dissemination of research findings. More comprehensive information on 
participant recruitment, enrollment, and engagement has been published previously23. Annual 
Questionnaires (AQ) are completed by participants to collect information on demographic 
characteristics and physical, mental, and social health. Topics in the AQ include health insurance 
coverage, diagnoses, surgeries and procedures, alcohol and substance use, lifestyle behaviors, 
sexual activity, social support, experiences of stigma and discrimination, and other identity-
related health topics23. Inclusion criteria for the PRIDE study included participants aged 18 years 
or older, identification as a sexual or gender minority, live in the United States, and the ability to 
read and understand English. From 7,327 responses of eligible participants who completed the 
2018 AQ, 2,574 (35%) were categorized as gender minority individuals and were included in this 
study.  
 
Demographics 
Using the participant-reported gender identity and sex assigned at birth variables, 
participants were assigned to transfeminine, transmasculine, and gender expansive groups, which 
were the population in our study. Previous papers with the PRIDE Study have detailed how we 
have measured gender identity in detail32. Free text responses for gender identity were reviewed 
for feminine, masculine, and nonbinary language to ensure gender categorization fits with how 
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they identify. Participants’ zip code was used to identify their state of residence and linked to the 
MAP database on level of healthcare policy protection. Additional covariates included in this 
study were age, sexual orientation, race/ethnicity, household income, education level, and 
insurance status (current insurance status and time uninsured in the past 12 months). Sex 
assigned at birth was included as a covariate for the gender expansive group. 
 
Healthcare Discrimination 
Participants were asked the following “yes”/”no” questions regarding healthcare 
discrimination: “Have you ever been denied or given lower quality medical care?” and “Have 
you ever been denied or given lower quality mental health care?” Participants who responded 
“yes” to either of these questions were coded as having experienced healthcare discrimination. 
Those who responded “yes” were asked if they experienced discrimination in the past year: “In 
the past year, have you been denied or given lower quality medical care?” and “In the past year, 
have you been denied or given lower quality mental health care?” Responses to having 
experienced discrimination recently was included as additional covariates in the analysis. 
 
Care Avoidance 
 Participants were asked “Was there a time in the PAST YEAR when you needed to see a 
healthcare provider but did not because you thought you would be disrespected or mistreated?” 
Those who answered “yes” were considered to be avoiding care. 
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Movement Advancement Project 
MAP is a nonprofit organization that provides structural-level data collection about 
existing LGBTQ-related policies and laws for the purpose of advancing policy, resources, and 
awareness for the LGBTQ population. MAP indexes the number of policies that protect or harm 
individuals based on sexual or gender identity in every state. A policy tally score based on the 
policies in place in each state was calculated. Positive points are assigned to policies that are 
protective for the LGBT population and negative points are assigned to policies that are harmful 
to this population. Fractions of points can be assigned for policies or laws that are partially 
enacted or for local laws that provide some protection within the state. States are categorized as 
negative, low, medium, and high equality based on the policy tally.  
 
State Healthcare Policy Tallies 
State policy tallies for healthcare were determined by six types of policies related to 
health and safety and the potential points: “hate crimes laws covering LGBT people” (0 to 1 
point), “private health insurance non-discrimination laws” (0 to 1 point), “health insurance 
providers banned from excluding coverage from transgender-specific care” (0 to 1 point), “state 
Medicaid policies related to coverage for transgender people” (-1 to 1 point), “transgender 
inclusive health benefits for state employees” (0 to 0.5 point), “state criminalizes exposure to 
and/or transmission of HIV” (-0.5 to 0 point). The total tally for gender identity policies ranges 
from -1.5 to 4.5 points. States are then categorized as having a harmful level of healthcare policy 
(-1.5 to 0 points) or protective level of health care policy (0.01 to 4.5 points). 
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DATA ANALYSIS 
Descriptive statistics were used to describe demographics and frequency of having 
experienced health care discrimination and care avoidance. T-tests and Pearson’s 𝜒2 tests were 
performed to determine two-way associations for healthcare discrimination and state healthcare 
policy tallies with covariates. Logistic regression models were used to identify the association 
between having experienced healthcare discrimination and care avoidance. Participant-reported 
location was used to link variables from the PRIDE Study database and the MAP database. 
Logistic regression models were used to identify associations between level of gender identity 
equality policies by state and care avoidance. Logistic regression models were used to compare 
the relationship between healthcare discrimination and care avoidance and the relationship 
between level of gender identity equality policies and care avoidance. Multivariable adjustment 
of the three models was used to control for relevant covariates (i.e. age, sexuality, race/ethnicity, 
household income and insurance status). All analyses were completed using Stata version 15 
(College Station, TX). 
 
RESULTS 
 There were a total of 2,574 participants across all three gender categories (n = 309 
transfeminine people, n = 580 transmasculine people, n = 1,675 gender expansive people). Mean 
ages of each gender category were 40.9 years (SD = 14.7; Range = 18 - 76) for the transfeminine 
group, 29.8 years (SD = 10.4; Range = 18 - 76) for the transmasculine group, and 29.3 years (SD 
= 9.6; Range = 18 - 76) for the gender expansive group (Table 1). Approximately one third of 
each gender category reported having experienced discrimination in a healthcare setting in their 
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lifetime. Lifetime healthcare discrimination was reported by 31.1% of transfeminine, 40.9% of 
transmasculine, and 36.3% of gender expansive groups. 
 Twenty-one states had state healthcare policy tallies of 0 or less (Figure 2). Across the 
gender groups, approximately 30 – 40% of participants from each gender category were living in 
a state with net neutral or negative level of policy protection for healthcare. Specifically, 117 
transfeminine participants, 232 transmasculine participants, and 546 gender expansive 
participants were living in states that had more harmful than protective policies overall (Table 2). 
 Table 3 shows the odds ratios (ORs) and 95% confidence intervals (95% CIs) from the 
logistic regression models that were used to assess for associations between healthcare 
discrimination and state healthcare policies with care avoidance. Model 1 showed that all three 
gender identity groups had higher odds of care avoidance after exposure to healthcare 
discrimination (ORs (95% CIs): 7.81 (3.35 - 17.15) in the transfeminine group, 3.15 (2.03 - 4.90) 
in the transmasculine group, and 4.31 (3.34 – 5.57) in the gender expansive group; P < 0.001 for 
all). Model 2 shows that the odds of experiencing care avoidance in the states with neutral or 
negative levels of healthcare policy protection among transfeminine (OR 1.42; 95% CI 0.7 – 
2.89), transmasculine group (OR 0.85; 95% CI 0.55 – 1.30),  and gender expansive (OR 1.13; 
95% CI 0.88 – 1.47) groups. None of these results were statistically significant. Model 3 
incorporated both predictors in the same logistic regression model. This model showed that, for 
all three gender identity groups, the odds of care avoidance associated with experiencing lifetime 
healthcare discrimination were greater than the odds of care avoidance for participants living in a 
state with harmful healthcare policies (ORs(95% CIs): 8.29 (3.75 –18.34) vs. 1.28 (0.67 – 2.44) 
in the transfeminine group, 3.15 (2.02 – 4.90) vs. 1.28 (0.83 – 1.98) in the transmasculine group, 
 10 
and 4.23 (3.28 – 5.47) vs. 1.21 (0.938 – 1.57) in the gender expansive group; P < 0.001 for 
lifetime healthcare discrimination predictors).  
 
DISCUSSION 
This study explored whether discrimination experiences and social environments are 
associated with care avoidance among gender minorities. For transfeminine, transmasculine, and 
gender expansive groups, 30 - 40% reported having experienced healthcare discrimination in 
their lifetime. This is consistent with previous studies’ characterization of the high occurrence of 
discrimination against transgender people in healthcare settings6,7,11,18. Despite growing visibility 
and acceptance of transgender or gender expansive people, discrimination remains highly 
prevalent.  
Consistent with past studies10,21, our findings support that experiencing healthcare 
discrimination in the past is associated with increased odds of avoiding care among transgender 
people. Avoiding care is a form of individual-level discrimination, a response to anticipatory 
healthcare discrimination. Care avoidance may result in reduced capability for trans individuals 
to access a critical resource such as healthcare. Supporting transgender people in developing 
ways to cope with the fear of mistreatment has been hypothesized as an intervention to increase 
trans individuals’ capacity in accessing care10,25. Addressing healthcare providers’ education in 
transgender health and transphobia may also be a strategy to reduce the likelihood of 
discrimination and increase access to care14,26,27.  Analyzing models for transfeminine, 
transmasculine, and gender expansive groups separately, we can compare relationships across 
gender categories. We found that the odds of care avoidance in transfeminine people who 
experienced healthcare discrimination in the past are 7.81, compared to odds of 3.15 in 
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transmasculine people, and 4.31 in gender expansive people. This finding is consistent with 
previous studies that show transfeminine people may experience the greatest severity of 
discrimination and therefore may require special consideration when it comes to providing 
resources to increase access to health care and address discrimination experiences7,10,28,29. 
Attitudes toward sexual and gender minorities vary by geographic location and is 
reflected in healthcare policies and how residents vote30,31. Prior studies have found states with 
more conservative voters have a higher prevalence of providers refusing care to transgender 
individuals, but have not found significant associations between protective policies for 
transgender individuals and lower instances of discrimination experiences 10. We have also not 
been able to find significant associations between overall state healthcare policies related to 
gender identity and care avoidance. It is possible that the MAP methods for scoring policies may 
not reflect the actual weight of each policy. Further studies should consider transgender policy 
protections beyond the realm of healthcare and other possible methods to measure structural-
level discrimination. Regardless, structural-level discrimination in the form of healthcare policies 
is associated with restricted access to healthcare for transgender individuals and may negatively 
impact health outcomes7,16,18. 
Comparing the associations between lifetime healthcare discrimination versus state 
healthcare policies with care avoidance, we found that experiencing healthcare discrimination 
remains statistically significant, while the policies do not. This suggests that, in our study, 
interpersonal-level factors have a stronger association to anticipated discrimination than 
structural-level factors. However, further studies that offer more nuanced assessment of 
structural factors are required. These findings may speak to how structural stigma is enacted 
 12 
through the interpersonal level and associated with negative impacts to health in transgender 
individuals6,12. 
 While this study provides insight into how discrimination experiences and political 
climate relate to anticipated discrimination behavior, the findings should be considered with 
some limitations. A cross-sectional study design does not allow for conclusions about cause and 
effect. Our study sample was predominately White, of higher education, and higher 
socioeconomic status based on household income (Table 1). Future studies with more diverse 
samples would allow for more detailed analysis of these relationships in other groups. Future 
studies also need to consider the unique challenges that transgender and gender expansive people 
with other health-related conditions (e.g., disabilities) may experience. 
 In conclusion, our study supports the hypothesis that discrimination is associated with 
decreased access to care for trans and gender expansive people and potentially negative health 
impacts. Interpersonal-level discrimination is more strongly associated with care avoidance than 
structural-level discrimination, although this could be due to difficulty in obtaining structural-
level data. People who identify as transfeminine reported the greatest odds for care avoidance 
and may require additional consideration for support and resources. It should be recognized that 
transgender discrimination extends beyond the healthcare setting and is linked with accessing 
other resources critical to life. Identifying the association between discrimination and care 
avoidance prompts the need for continued research and establishing resources to address fears of 
mistreatment or disrespect in healthcare settings for transgender and gender expansive people. 
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Figure 1. Modified social-ecological model of transgender stigma 
 
 
 
 
 
 
 
 
Figure 2. Map of states with harmful or protective healthcare policies regarding gender identity 
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e policies regarding gender identity 
 
 
 
 
Table 1. Demographic characteristics and discrimination experiences of gender minority 
participants in the 2018 PRIDE study annual questionnaire 
Table 1. Demographic characteristics of 2018 PRIDE study participants 
 
Table 2. Number of participants residing in states with overall harmful or protective state 
policies for gender minorities 
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Table 2. Participants residing in states with harmful or protective state policies  
Healthcare Policy Tally (%) Transfeminine  Transmasculine  Gender Expansive  
Living in Harmful State  117(37.9) 232(40.0) 546(32.4) 
Living in Protective State  192(51.1) 348(60.0) 1139(57.6) 
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